Mark A. Kluth

1.1k total citations
25 papers, 426 citations indexed

About

Mark A. Kluth is a scholar working on Genetics, Molecular Biology and Surgery. According to data from OpenAlex, Mark A. Kluth has authored 25 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 6 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Mark A. Kluth's work include Mesenchymal stem cell research (11 papers), Skin and Cellular Biology Research (5 papers) and Corneal Surgery and Treatments (5 papers). Mark A. Kluth is often cited by papers focused on Mesenchymal stem cell research (11 papers), Skin and Cellular Biology Research (5 papers) and Corneal Surgery and Treatments (5 papers). Mark A. Kluth collaborates with scholars based in United States, Australia and Germany. Mark A. Kluth's co-authors include Christoph Ganss, Markus H. Frank, Natasha Y. Frank, Karin Scharffetter‐Kochanek, Elke Niebergall‐Roth, Anca Sindrilaru, Mona Saffarzadeh, Meinhard Wlaschek, Qi Yu and Seppe Vander Beken and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Mark A. Kluth

24 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark A. Kluth United States	9	182	147	63	62	57	25	426
Holger Schlüter Germany	12	241 1.3×	75 0.5×	113 1.8×	51 0.8×	52 0.9×	21	565
Chufa He United States	12	86 0.5×	100 0.7×	38 0.6×	133 2.1×	49 0.9×	17	379
Ah Young Ko South Korea	8	93 0.5×	153 1.0×	28 0.4×	71 1.1×	71 1.2×	9	398
Yohei Natsuaki Japan	9	76 0.4×	134 0.9×	31 0.5×	36 0.6×	119 2.1×	16	547
Julia Etich Germany	16	276 1.5×	37 0.3×	51 0.8×	36 0.6×	70 1.2×	25	557
Matt Weaver United States	8	142 0.8×	37 0.3×	43 0.7×	57 0.9×	23 0.4×	8	438
Dejin Zheng China	10	180 1.0×	117 0.8×	17 0.3×	90 1.5×	39 0.7×	16	365
Takenao Chino Japan	9	166 0.9×	96 0.7×	155 2.5×	52 0.8×	72 1.3×	21	496
Yuanfeng Jiang China	9	265 1.5×	63 0.4×	21 0.3×	33 0.5×	40 0.7×	30	484
Ryusuke Momota Japan	12	149 0.8×	29 0.2×	87 1.4×	43 0.7×	25 0.4×	24	419

Countries citing papers authored by Mark A. Kluth

Since Specialization

Citations

This map shows the geographic impact of Mark A. Kluth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Kluth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Kluth more than expected).

Fields of papers citing papers by Mark A. Kluth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Kluth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Kluth. The network helps show where Mark A. Kluth may publish in the future.

Co-authorship network of co-authors of Mark A. Kluth

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Kluth. A scholar is included among the top collaborators of Mark A. Kluth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Kluth. Mark A. Kluth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Niebergall‐Roth, Elke & Mark A. Kluth. (2025). Dimethyl sulfoxide in cryopreserved mesenchymal stromal cell therapy products: is there a safety risk to patients?. Journal of Translational Medicine. 23(1). 932–932. 2 indexed citations

Kluth, Mark A., Christoph Ganss, Markus H. Frank, et al.. (2024). Anti-Inflammatory and Anti-(Lymph)angiogenic Properties of an ABCB5+ Limbal Mesenchymal Stem Cell Population. International Journal of Molecular Sciences. 25(17). 9702–9702. 1 indexed citations

Rendra, Erika, Adriana Torres Crigna, Carsten Sticht, et al.. (2024). Clinical-grade human skin-derived ABCB5+ mesenchymal stromal cells exert anti-apoptotic and anti-inflammatory effects in vitro and modulate mRNA expression in a cisplatin-induced kidney injury murine model. Frontiers in Immunology. 14. 1228928–1228928. 3 indexed citations

Niebergall‐Roth, Elke, Jasmina Esterlechner, Markus H. Frank, et al.. (2024). Potency assay to predict the anti-inflammatory capacity of a cell therapy product for macrophage-driven diseases: overcoming the challenges of assay development and validation. Cytotherapy. 26(5). 512–523. 3 indexed citations

Niebergall‐Roth, Elke, Natasha Y. Frank, Christoph Ganss, et al.. (2023). ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa. Cytotherapy. 25(7). 782–788. 10 indexed citations

Hou, Yanhong, Mark A. Kluth, Christoph Ganss, et al.. (2023). ABCB5+ Limbal Epithelial Stem Cells Inhibit Developmental but Promote Inflammatory (Lymph) Angiogenesis While Preventing Corneal Inflammation. Cells. 12(13). 1731–1731. 3 indexed citations

Keese, Michael, Kaixuan Yan, Karen Bieback, et al.. (2023). Adipose-Derived Mesenchymal Stem Cells Protect Endothelial Cells from Hypoxic Injury by Suppressing Terminal UPR In Vivo and In Vitro. International Journal of Molecular Sciences. 24(24). 17197–17197. 5 indexed citations

Yan, Kaixuan, Mark A. Kluth, Lin Li, et al.. (2023). ABCB5+ mesenchymal stromal cells therapy protects from hypoxia by restoring Ca2+ homeostasis in vitro and in vivo. Stem Cell Research & Therapy. 14(1). 24–24. 2 indexed citations

Niebergall‐Roth, Elke, Maria Khokhrina, Inês Silva, et al.. (2023). Kinetics of Wound Development and Healing Suggests a Skin-Stabilizing Effect of Allogeneic ABCB5+ Mesenchymal Stromal Cell Treatment in Recessive Dystrophic Epidermolysis Bullosa. Cells. 12(11). 1468–1468. 4 indexed citations

10.

Niebergall‐Roth, Elke, et al.. (2023). Drug Regulatory-Compliant Validation of a qPCR Assay for Bioanalysis Studies of a Cell Therapy Product with a Special Focus on Matrix Interferences in a Wide Range of Organ Tissues. Cells. 12(13). 1788–1788. 1 indexed citations

11.

Kluth, Mark A., Christoph Ganss, Markus H. Frank, et al.. (2022). Consecutive dosing of UVB irradiation induces loss of ABCB5 expression and activation of EMT and fibrosis proteins in limbal epithelial cells similar to pterygium epithelium. Stem Cell Research. 64. 102936–102936. 3 indexed citations

12.

Niebergall‐Roth, Elke, Natasha Y. Frank, Christoph Ganss, Markus H. Frank, & Mark A. Kluth. (2022). Skin-Derived ABCB5+ Mesenchymal Stem Cells for High-Medical-Need Inflammatory Diseases: From Discovery to Entering Clinical Routine. International Journal of Molecular Sciences. 24(1). 66–66. 8 indexed citations

13.

Esterlechner, Jasmina, Elke Niebergall‐Roth, Seda Ballikaya, et al.. (2021). Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency. Stem Cell Research & Therapy. 12(1). 194–194. 25 indexed citations

14.

Ballikaya, Seda, Elke Niebergall‐Roth, Nicole Bauer, et al.. (2020). Process data of allogeneic ex vivo-expanded ABCB5+ mesenchymal stromal cells for human use: off-the-shelf GMP-manufactured donor-independent ATMP. Stem Cell Research & Therapy. 11(1). 482–482. 20 indexed citations

15.

Niebergall‐Roth, Elke, Andreas Kerstan, Jasmina Esterlechner, et al.. (2019). In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials. Cytotherapy. 21(5). 546–560. 35 indexed citations

16.

Dewidar, Bedair, Tao Lin, Christoph Ganss, et al.. (2019). Human skin-derived ABCB5+ stem cell injection improves liver disease parameters in Mdr2KO mice. Archives of Toxicology. 93(9). 2645–2660. 7 indexed citations

17.

Notara, Maria, Mark A. Kluth, Christoph Ganss, et al.. (2018). UV light-blocking contact lenses protect against short-term UVB-induced limbal stem cell niche damage and inflammation. Scientific Reports. 8(1). 12564–12564. 22 indexed citations

18.

Winkler, Sandra, et al.. (2018). Assessment of the hepatocytic differentiation ability of human skin-derived ABCB5+ stem cells. Experimental Cell Research. 369(2). 335–347. 3 indexed citations

19.

Webber, Beau R., Ron McElmurry, Cindy Eide, et al.. (2017). Rapid generation of Col7a1−/− mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cells. Laboratory Investigation. 97(10). 1218–1224. 29 indexed citations

20.

Altmeppen, Hermann C., Johannes Prox, Berta Puig, et al.. (2011). Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo. Molecular Neurodegeneration. 6(1). 36–36. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact